← All Sponsors
SPONSOR

Polaris Group

Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Hepatocellular CarcinomaAdvanced Hepatocellular Carcinoma
NCT05317819 Phase 3
Recruiting

Study of ADI-PEG 20 Versus Placebo in Subjects With High Arginine Level and Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma
Taiwan, Vietnam View Trial →